← Browse by Condition
Medical Condition
metastatic brain tumor
Total Trials
2
Recruiting Now
2
Trial Phases
Phase 2, Phase 1
NCT06161974 Phase 2
Recruiting
Study of Olutasidenib and Temozolomide in HGG
Enrollment
60 pts
Location
United States, Austr...
Sponsor
Rigel Pharmaceuticals
NCT05556473 Phase 1
Recruiting
F-Tryptophan PET/CT in Human Cancers
Enrollment
24 pts
Location
United States
Sponsor
Barbara Ann Karmanos Cancer In...